Results 71 to 80 of about 189,087 (191)

Quantitative optical coherence tomography angiography biomarkers in a treat-and-extend dosing regimen in neovascular age-related macular degeneration [PDF]

, 2020
Purpose: To evaluate the association between quantitative optical coherence tomography angiography (OCT-A) parameters and clinical outcomes in treatment-naïve neovascular age-related macular degeneration (nAMD) patients treated with a treat-and-extend ...
Cabral, Diogo, Cohen, Salomon Yves, Coscas, Florence, Coscas, Gabriel, Falcão, Manuel, Français, Catherine, Geraldes, Carlos, Kashi, Alexis Khorrami, Laiginhas, Rita, Lupidi, Marco, Nogueira, Vanda, Papoila, Ana Luísa, Pereira, Telmo, Rodrigues, Catarina, Souied, Eric   +14 more
core   +1 more source

TREAT-AND-EXTEND BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Retina, 2014
To evaluate the factors affecting visual and anatomical outcomes and the number of intravitreal bevacizumab injections required in the treatment of neovascular age-related macular degeneration using a treat-and-extend regimen.Retrospective consecutive case series.
Rush, R, Simunovic, M, Vandiver, L, Aragon, A, Ysasaga, J   +4 more
openaire   +2 more sources

Survival of patients treated with extended-hours haemodialysis in Europe: an analysis of the ERA-EDTA Registry [PDF]

Nephrology Dialysis Transplantation, 2019
Abstract Background Previous US studies have indicated that haemodialysis with ≥6-h sessions [extended-hours haemodialysis (EHD)] may improve patient survival. However, patient characteristics and treatment practices vary between the USA and Europe.
Thijs T Jansz, Marlies Noordzij, Anneke Kramer, Eric Laruelle, Cécile Couchoud, Frederic Collart, Aleix Cases, Mustafa Arici, Jaako Helve, Bård Waldum-Grevbo, Helena Rydell, Jamie P Traynor, Carmine Zoccali, Ziad A Massy, Kitty J Jager, Brigit C van Jaarsveld   +15 more
openaire   +6 more sources

Real-world short-term outcomes after switching to fixed-interval anti-VEGF therapy for neovascular AMD during the COVID-19 pandemic

International Journal of Retina and Vitreous
Purpose To assess short-term real-world visual and anatomic outcomes in patients with neovascular age-related macular degeneration (nvAMD) following a protocol shift from an individualized treat-and-extend (T&E) anti-VEGF regimen to a fixed-interval ...
Arnulfo Garza Reyes, Tirth J. Shah, Edward F. Linton, Zachary Q. Mortensen, Timothy M. Boyce, Aaron M. Ricca, Razek G. Coussa, H. Culver Boldt, James C. Folk, Stephen R. Russell, Ian C. Han, Karen M. Gehrs, Elliott H. Sohn   +12 more
doaj   +1 more source

Intravitreal treatment in patients with exudative age-related macular degeneration and visual acuity ≤ 0.05

, 2016
Background: To investigate intravitreal treatment efficiencies in patients suffering from exudative ARMD with a BCVA ≤ 0.05. Methods: Retrospective analysis: Analysis parameters were lesion type, BCVA at baseline and at follow-up, the intravitreal drug ...
Busse, H. (Holger), Gebauer, S.M.I. (Sabine), Koch, R. (Raphael), Schmidt, M. (Matthias), Uhlig, C. (Constantin)   +4 more
core   +1 more source

Review of Guideline Recommendations for Optimal Anti-VEGF Therapy in Age-Related Macular Degeneration

Life
Neovascular age-related macular degeneration is a progressive, blinding macular disease that has become a burden both in healthcare systems and the global economy. The vascular endothelial growth factor (VEGF) is the main agent involved in the pathogenic
Andreea Dana Moraru, Ciprian Danielescu, Raluca Eugenia Iorga, Radu Lucian Moraru, Mihail Zemba, Daniel Constantin Branisteanu   +5 more
doaj   +1 more source

Treat-And-Extend Regimens with Anti-Vegf Agents in Retinal Diseases

Retina, 2015
PURPOSE: A review of treat-and-extend regimens (TERs) with intravitreal anti-vascular endothelial growth factor agents in retinal diseases. METHODS: There is a lack of consensus on the definition and optimal application of TER in clinical practice. This article describes the supporting evidence and subsequent development of a generic algorithm for TER ...
Freund, K. Bailey, Korobelnik, Jean François, Devenyi, Robert, Framme, Carsten, Galic, John, Herbert, Edward, Hoerauf, Hans, LANZETTA, Paolo, Michels, Stephan, Mitchell, Paul, Monés, Jordi, Regillo, Carl, Tadayoni, Ramin, Talks, James, Wolf, Sebastian   +14 more
openaire   +6 more sources

Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group

Clinical Ophthalmology, 2018
Winfried Amoaku,1 Konstantinos Balaskas,2,3 Tomas Cudrnak,4 Louise Downey,5 Markus Groppe,6 Sajjad Mahmood,7 Hemal Mehta,8 Quresh Mohamed,9 Bushra Mushtaq,10 Philip Severn,11 Athanasios Vardarinos,12 Yit Yang,13 Saad Younis14 1Academic Ophthalmology ...
Amoaku W, Balaskas K, Cudrnak T, Downey L, Groppe M, Mahmood S, Mehta H, Mohamed Q, Mushtaq B, Severn P, Vardarinos A, Yang Y, Younis S   +12 more
doaj  

Confluent and reticulated papillomatosis treated with extended-release minocycline

Indian Dermatology Online Journal, 2023
Fathima Shafi, M Manjunath Shenoy, Deepa M Thomas, Malcolm Pinto   +3 more
openaire   +3 more sources

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update

Clinical Ophthalmology, 2017
Praveen J Patel,1 Helen Devonport,2 Sobha Sivaprasad,1 Adam H Ross,3 Gavin Walters,4 Richard P Gale,5 Andrew J Lotery,6 Sajjad Mahmood,7 James S Talks,8 Jackie Napier9 1National Institute for Health Research Biomedical Research Centre at Moorfields Eye ...
Patel PJ, Devonport H, Sivaprasad S, Ross AH, Walters G, Gale RP, Lotery AJ, Mahmood S, Talks JS, Napier J   +9 more
doaj